← brief for 2026-10-09 · Slowing decline

GLP-1 receptor agonists and serious adverse events: Evidence, uncertainty and clinical implications.

Key takeaways

This review looks at the safety of common diabetes drugs called GLP-1s. It checks for rare but serious side effects like thyroid cancer or pancreatitis. It is a summary of existing studies, not a new test with new results.

Who did this work

Ueda P

Source

Paper · PubMed, the drug frontier · 2026 Oct 9
https://pubmed.ncbi.nlm.nih.gov/42851139/